Home » Pharmacology » Ion Channels » Ligand-gated Ion Channels » Glutamate (Ionotropic) Receptors » NMDA Receptors » (R)-4-Carboxyphenylglycine

(R)-4-Carboxyphenylglycine

Cat. No. 0322

Price and Availability

For (R)-4-Carboxyphenylglycine pricing & availability please select your country from the drop down menu:
Submit

By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Alternative Name: (R)-4CPG

Biological Activity

Moderately potent NMDA receptor antagonist. (RS)-4-Carboxyphenylglycine (Cat. No. 0321) and (S)-4-Carboxyphenylglycine (Cat. No. 0323) also available.

Technical Data

M.Wt:

195.17

Formula:

C₉H₉NO₄

Solubility:

Soluble to 100 mM in 1eq. NaOH and to 5 mM in water

Purity:

>98 %

Storage:

Store at RT

CAS No:

134052-68-9

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Resources

Other Information

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis is currently unavailable on-line. Please contact Customer Service

Safety Data Sheet: View Safety Data Sheet

References

Jones et al (1993) Agonist and antagonist actions of phenylglycine derivatives at depolarization-mediating (1S,3R)-ACPD receptors in neonatal rat motoneurones. Br.J.Pharmacol. 108 86P.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Glutamate (Ionotropic) Receptors

NMDA Receptors

Keywords: (R)-4-Carboxyphenylglycine, supplier, Moderately, potent, NMDA, antagonists, Glutamate, Receptors, N-Methyl-D-Aspartate, iGluR, Ionotropic

Quick Order

Find multiple products by catalog number

Pain Research Guide

Reserve your free copy

Highlights over 280 products for Pain research. Reserve copy

Therapeutic Strategies in Schizophrenia

Written by J. Lieberman

'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development.

Calcium Imbalance and Neuroprotective Targets

Written by E. Besancon et al

'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.

Neurobiology of Parkinson's Disease

Written by A. Schapira

'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and summarizes current and novel therapeutic interventions.